Literature DB >> 10656299

Differential oxidation of apolipoprotein E isoforms and interaction with phospholipids.

C Jolivalt1, B Leininger-Muller, P Bertrand, R Herber, Y Christen, G Siest.   

Abstract

Accumulation of oxidized proteins has been demonstrated in the brain of patients suffering from Alzheimer's disease (AD). Among the proteins found in cerebral amyloid deposits, apolipoprotein (apo) E is a polymorphic protein which one specific isoform, apo E4, has been widely associated with AD. Apo E may be linked with AD by its isoform-specific interaction with lipids or other proteins in amyloid plaques. Using the myeloperoxidase oxidative system, we report that oxidation of the three recombinant apo E isoforms is differential (as estimated using immunoblot and high-performance liquid chromatography analysis), with apo E4 being more susceptible than apo E3, which in turn is much more susceptible than apo E2. In addition, susceptibility to thrombin proteolysis is reduced when apo E is oxidized, and oxidation of apo E decreases its incorporation into phospholipid discs by approximately 50%. Oxidation of apo E may contribute to inefficient lipid recycling in the brain, particularly regarding apo E4 and E3. Our results link and strengthen both the E4 allele linkage with AD and the role of protein oxidation in AD. The cerebral mechanisms underlying apo E oxidation and/or myeloperoxidase functions in vivo remain to be assessed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10656299     DOI: 10.1016/s0891-5849(99)00232-4

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

1.  Myeloperoxidase: a new twist to an old tale.

Authors:  Usha Anand; C V Anand
Journal:  Indian J Clin Biochem       Date:  2012-05-08

2.  Evaluation of APOE Genotype and Ability to Perform Activities of Daily Living Following Aneurysmal Subarachnoid Hemorrhage.

Authors:  Lacey Wright Heinsberg; Eleanor Turi; Dianxu Ren; Elizabeth Crago; Sheila Alexander; Ansley Grimes Stanfill; Yvette Perry Conley
Journal:  Biol Res Nurs       Date:  2017-12-19       Impact factor: 2.522

3.  Apolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.

Authors:  Theresa A Koleck; Catherine M Bender; Susan M Sereika; Gretchen Ahrendt; Rachel C Jankowitz; Kandace P McGuire; Christopher M Ryan; Yvette P Conley
Journal:  Oncol Nurs Forum       Date:  2014-11-01       Impact factor: 2.172

4.  Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans.

Authors:  Marion Dietrich; Youqing Hu; Gladys Block; Estibaliz Olano; Lester Packer; Jason D Morrow; Mark Hudes; Gulbahar Abdukeyum; Gerald Rimbach; Anne M Minihane
Journal:  Lipids       Date:  2005-04       Impact factor: 1.880

Review 5.  Dietary lipids in the aetiology of Alzheimer's disease: implications for therapy.

Authors:  Janelle L Cooper
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Selenium level is associated with apoE epsilon4 in rural elderly Chinese.

Authors:  Sujuan Gao; Yinlong Jin; Kathleen S Hall; Chaoke Liang; Frederick W Unverzagt; Feng Ma; Yibin Cheng; Jianzhao Shen; Jingxiang Cao; Janetta Matesan; Ping Li; Jianchao Bian; Hugh C Hendrie; Jill R Murrell
Journal:  Public Health Nutr       Date:  2009-03-12       Impact factor: 4.022

7.  Can APOE and MTHFR polymorphisms have an influence on the severity of cardiovascular manifestations in Italian Pseudoxanthoma elasticum affected patients?

Authors:  Federica Boraldi; Sonia Costa; Claudio Rabacchi; Miriam Ciani; Olivier Vanakker; Daniela Quaglino
Journal:  Mol Genet Metab Rep       Date:  2014-11-16

8.  VPO1 mediates ApoE oxidation and impairs the clearance of plasma lipids.

Authors:  Youfeng Yang; Zehong Cao; Ling Tian; W Timothy Garvey; Guangjie Cheng
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

Review 9.  A systematic review and meta-analysis of 130,000 individuals shows smoking does not modify the association of APOE genotype on risk of coronary heart disease.

Authors:  Michael V Holmes; Ruth Frikke-Schmidt; Daniela Melis; Robert Luben; Folkert W Asselbergs; Jolanda M A Boer; Jackie Cooper; Jutta Palmen; Pia Horvat; Jorgen Engmann; Ka-Wah Li; N Charlotte Onland-Moret; Marten H Hofker; Meena Kumari; Brendan J Keating; Jaroslav A Hubacek; Vera Adamkova; Ruzena Kubinova; Martin Bobak; Kay-Tee Khaw; Børge G Nordestgaard; Nick Wareham; Steve E Humphries; Claudia Langenberg; Anne Tybjaerg-Hansen; Philippa J Talmud
Journal:  Atherosclerosis       Date:  2014-08-15       Impact factor: 5.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.